학술논문
Defining the optimal formulation and schedule of a candidate toxoid vaccine against Clostridium difficile infection: A randomized Phase 2 clinical trial
Document Type
Article
Author
de Bruyn, G.; Ozol-Godfrey, A.; Patel, D.M.; Pietrobon, P.J.; Gesser, R.; Saleh, J.; Workman, D.; Pollak, R.; Elinoff, V.; Fraser, N.J.; Lefebvre, G.; Martens, M.; Mills, R.E.; Nathan, R.; Trevino, M.; van Cleeff, M.; Foglia, G.; Arslanian, A.; Gagianas, P.; Brookmyre, A.; Christensen, S.; Henry, D.; Cook, R.; Earl, J.; Eder, F.; Evans, P.; Glover, R.; Haselby, R.; Hoekstra, J.; Radin, D.; Rosen, J.; Rubino, J.; Segall, N.; White, A.; Yangco, B.; Zakko, S.; Ervin, J.; Casanova, R.; Griffin, C.; Weiner, G.; Barish, C.; Kapoor, O.; Fernandez, M.; Epstein, R.; Poling, T.; Lesh, K.; Challa, V.; Farrington, C.; Bauch, T.; Chen, M.; Arora, S.
Source
In: Vaccine . (Vaccine, 27 April 2016, 34(19):2170-2178)
Subject
Language
English
ISSN
18732518
0264410X
0264410X